Snowball logo
logo
URT

Urteste SA

URT WAR
43.800.00  (0%)
Estimate
EPS
-4.94
Beta
0.213
Growth
Revenue, YoY
-99.72%
Net income, YoY
-150.95%
FCF, YoY
-39.41%
About the company
Ticker
URT
ISIN
PLURTST00010
Country
Poland
Sector (GICS)
Healthcare
Urteste S.A. engages in the research and development of diagnostic tests for cancers in Poland. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, bile ducts, stomach, lung, esophagus, ovary, endometrium, blood, breast, and brain. The company was incorporated in 2021 and is based in Gdansk, Poland.

Frequently asked questions

What sector does Urteste SA (URT) operate in?

Urteste SA belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Urteste SA (URT) current stock price?

As of the latest data, Urteste SA stock price is PLN 43.80, with a previous close of PLN 43.80.

What is Urteste SA (URT) current market capitalization?

Urteste SA market cap is approximately 66.84 million.

What is Urteste SA (URT) Earnings Per Share (EPS)?

The trailing EPS is -PLN 4.94.

What is Urteste SA (URT) EBITDA?

Urteste SA EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.46 million.

Does Urteste SA (URT) pay dividends?

No. Urteste SA does not pay a dividend.

What is Urteste SA (URT) beta (volatility) score?

Urteste SA has a beta of 0.213, indicating lower volatility than the overall market.